The
in vitro activity of 4 carbapenem antibiotics, i. e., biapenem (BIPM), meropenem (MEPM), imipenem (IPM), and panipenem (PAPM), ampicillin, 2 cephalosporins, and vancomycin (VCM), was determined by the agar dilution method against 200 strains of
Streptococcus pneumoniae isolated from patients with respiratory tract infections, acute otitis media, and purulent meningitis. Based on penicillin-binding proteins (PBPs) gene analysis by polymerase chain reaction, the prevalence of PSSP (penicillin-susceptible S. pneumoniae), PISP (penicillin-intermediate resistant
S. pneumoniae), and PRSP (penicillin-resistant
S. pneumoniae) was 51, 71 and 78 strains. MICs
50, and MICs
90, were as follows: 2 and 4, μg/mL ampicillin, 1 and 1, μg/mL cefotaxime (CTX), 4 and 8, μg/mL cefotiam, 0.125 and 0.25, μg/mL IPM, 0.063 and 0.125, μg/mL PAPM, 0.5 and 0.5, μg/mL MEPM, 0.25 and 0.5, μgmL BIPM, and 0.25 and 0.5, μg/mL VCM. Th bactericidal activity of carbapenems against 2 PRSP strains was significantly higher than that of cephalosporins. There was little difference among the activities of 4 carbapenems at concentrations lower than the breakpoint (1-2, μg/mL) recommended by the Japanese Society of Chemotherapy. PRSP strain ME-19 (serotype 19 F) was examined under a scanning electron microscope after exposure to BIPM, MEPM, or CTX at the MIC for 3 h. Peptidoglycan synthesis in the direction of the long axis and constriction in the septal region were inhibited by BIPM and MEPM. Cell lysis was observed near the septum as if a part of the cell wall was pulled apart. CTX inhibited septal synthesis and, as a result, filamentous cells were formed. Peptidoglycan synthesis in the long axis was almost normal, and only a few cells were lysed by short-term observation. From these results, we speculate that the clinical effect of the 4 carbapenems against pneumonia and sepsis cases caused by PRSP can be expected at the same level of activity when a host does not have a risk factor.
View full abstract